To date, about 100 Xarelto lawsuits filed in federal court systems have been centralized into a multidistrict litigation (MDL), which is proceeding in the U.S. District Court for the Eastern District of Louisiana. Judge Eldon E. Fallon is presiding over the MDL, which was established in December 2014 by the... Read more »

Testosterone replacement therapy has been touted as the key to male vitality, enhanced libido and physical performance. After all, this powerful male hormone helps guys maintain muscle mass, sperm production and the all-important sex drive. Some four percent of men in their 60’s are taking testosterone supplements, according to a... Read more »

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »

Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas recently issued an order that has created a mass tort docket for Xarelto lawsuits filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals. The January 21, 2015 order affects at least 75 cases that share common allegations regarding the medication,... Read more »

A new order permitting the direct filing of testosterone lawsuits into federal multidistrict litigation (MDL) has been issued by U.S. District Judge Matthew Kennelly, in the Northern District of Illinois. Judge Kennelly has been appointed to oversee the MDL ─ established in June 2014 ─ which includes lawsuits from plaintiffs... Read more »

The Janssen unit of Johnson & Johnson recently announced a Xarelto recall due to the discovery of a microbial contamination. To date, information regarding the exact nature of the contamination has not been released and so far it appears that no patients have suffered an illness because of the problem.... Read more »

Pharmaceutical giant Bayer has already resolved more than 17,000 Yaz and Yasmin lawsuits involving venous clot injuries, pulmonary embolism and deep vein thrombosis, but hundreds more are still pending in multidistrict litigation No. 2100. While the MDL is still marshalling discovery common to all cases, the presiding Judge, Honorable David... Read more »

On August 15, the Alabama Supreme Court ruled that brand name prescription drug makers can be held liable for claims brought by plaintiffs seeking damages for adverse side effects from generic drugs manufactured by different companies. In an overwhelming 6-3 decision, the court ruled that the manufacturers of Reglan ─... Read more »

Bayer Healthcare, a pharmaceutical giant, revealed the resolution of thousands of Yaz lawsuits in its second quarter financial report for 2014. The company and over 17,000 claimants agreed to a settlement of over $1.8 billion. The plaintiffs had sued Bayer with regard to life-threatening side effects that were allegedly caused... Read more »

In what is likely a precursor to the Food and Drug Administration taking regulatory action on low testosterone replacement therapy (TRT), the FDA has asked two advisory committees to meet on September 17 to evaluate the risks and reported testosterone side effects linked to so-called “Low T” drugs, such as AndroGel, Testim,... Read more »